Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer

Fig. 3

The expression of (A) Bcl-XL and (B) Mcl-1 genes, after administration of naringenin (50 mg/kg/day) (Nar) and CPT (20 mg/kg/day) either individually or together (both at the concentration of 20 mg/kg/day). The expression of genes were measured by real-time PCR and analyzed using ΔΔCt method. * P < 0.05, **P < 0.01, P < 0.001, compared to control

Back to article page